tiprankstipranks
Trending News
More News >
Elevance Health (ELV)
NYSE:ELV
US Market

Elevance Health (ELV) Ratios

Compare
2,858 Followers

Elevance Health Ratios

ELV's free cash flow for Q3 2025 was $0.14. For the 2025 fiscal year, ELV's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.00 1.45 2.05 1.40 2.07
Quick Ratio
0.00 1.45 2.05 1.69 3.86
Cash Ratio
0.00 0.20 0.25 0.19 0.23
Solvency Ratio
0.09 0.10 0.11 0.11 0.12
Operating Cash Flow Ratio
0.00 0.14 0.31 0.21 0.39
Short-Term Operating Cash Flow Coverage
5.29 2.88 4.30 4.76 4.46
Net Current Asset Value
$ -78.67B$ -16.52B$ -15.52B$ -10.76B$ -16.59B
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.27 0.23 0.23 0.24
Debt-to-Equity Ratio
0.73 0.76 0.64 0.66 0.64
Debt-to-Capital Ratio
0.42 0.43 0.39 0.40 0.39
Long-Term Debt-to-Capital Ratio
0.41 0.41 0.37 0.38 0.37
Financial Leverage Ratio
2.79 2.83 2.77 2.83 2.70
Debt Service Coverage Ratio
3.66 2.67 3.02 3.22 1.56
Interest Coverage Ratio
5.42 6.67 8.49 9.93 11.21
Debt to Market Cap
0.39 0.36 0.23 0.20 0.20
Interest Debt Per Share
148.26 139.21 112.20 104.02 97.74
Net Debt to EBITDA
2.34 2.19 1.77 1.65 3.02
Profitability Margins
Gross Profit Margin
77.66%100.00%27.44%25.51%25.96%
EBIT Margin
4.35%5.14%5.10%5.40%3.39%
EBITDA Margin
5.14%5.93%6.12%6.47%4.33%
Operating Profit Margin
3.83%4.47%5.10%5.40%6.45%
Pretax Profit Margin
3.64%4.47%4.50%4.85%5.72%
Net Profit Margin
2.84%3.38%3.49%3.76%4.40%
Continuous Operations Profit Margin
2.84%3.38%3.50%3.76%4.44%
Net Income Per EBT
77.92%75.66%77.60%77.55%77.02%
EBT Per EBIT
95.29%100.00%88.22%89.93%88.59%
Return on Assets (ROA)
4.51%5.12%5.50%5.74%6.27%
Return on Equity (ROE)
12.91%14.47%15.23%16.23%16.93%
Return on Capital Employed (ROCE)
6.07%10.36%10.58%13.40%11.80%
Return on Invested Capital (ROIC)
624.46%29.31%8.04%10.07%7.44%
Return on Tangible Assets
6.67%7.82%8.16%8.66%9.77%
Earnings Yield
6.59%6.96%5.45%4.79%5.40%
Efficiency Ratios
Receivables Turnover
8.72 9.27 9.59 17.48 17.87
Payables Turnover
1.87 0.00 5.40 20.80 5.55
Inventory Turnover
0.00 0.00 0.00 -10.25 -2.67
Fixed Asset Turnover
41.83 38.01 39.31 36.28 35.38
Asset Turnover
1.59 1.51 1.57 1.52 1.42
Working Capital Turnover Ratio
0.00 9.66 6.46 8.03 6.25
Cash Conversion Cycle
-152.98 39.37 -29.53 -32.27 -182.16
Days of Sales Outstanding
41.87 39.37 38.06 20.89 20.43
Days of Inventory Outstanding
0.00 0.00 0.00 -35.61 -136.84
Days of Payables Outstanding
194.85 0.00 67.58 17.55 65.74
Operating Cycle
41.87 39.37 38.06 -14.73 -116.42
Cash Flow Ratios
Operating Cash Flow Per Share
21.75 24.94 34.59 35.00 34.31
Free Cash Flow Per Share
16.68 19.55 29.03 30.20 29.85
CapEx Per Share
5.07 5.39 5.56 4.80 4.46
Free Cash Flow to Operating Cash Flow
0.77 0.78 0.84 0.86 0.87
Dividend Paid and CapEx Coverage Ratio
1.84 2.10 3.00 3.53 3.82
Capital Expenditure Coverage Ratio
4.29 4.62 6.22 7.29 7.69
Operating Cash Flow Coverage Ratio
0.15 0.19 0.32 0.35 0.36
Operating Cash Flow to Sales Ratio
0.03 0.03 0.05 0.05 0.06
Free Cash Flow Yield
4.56%5.30%6.16%5.89%6.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.19 14.37 18.36 20.89 18.51
Price-to-Sales (P/S) Ratio
0.42 0.49 0.64 0.79 0.82
Price-to-Book (P/B) Ratio
1.91 2.08 2.80 3.39 3.13
Price-to-Free Cash Flow (P/FCF) Ratio
21.96 18.87 16.25 16.99 15.53
Price-to-Operating Cash Flow Ratio
17.11 14.79 13.63 14.66 13.51
Price-to-Earnings Growth (PEG) Ratio
3.73 8.48 3.98 -10.93 0.50
Price-to-Fair Value
1.91 2.08 2.80 3.39 3.13
Enterprise Value Multiple
10.60 10.38 12.25 13.81 21.85
Enterprise Value
105.98B 108.85B 128.50B 139.84B 131.16B
EV to EBITDA
10.58 10.38 12.25 13.81 21.85
EV to Sales
0.54 0.62 0.75 0.89 0.95
EV to Free Cash Flow
28.13 23.91 18.99 19.30 18.02
EV to Operating Cash Flow
21.58 18.74 15.94 16.65 15.68
Tangible Book Value Per Share
19.06 4.53 16.37 7.07 5.27
Shareholders’ Equity Per Share
194.65 177.42 168.64 151.28 147.91
Tax and Other Ratios
Effective Tax Rate
0.22 0.24 0.22 0.23 0.23
Revenue Per Share
862.80 759.28 735.14 652.48 568.66
Net Income Per Share
24.50 25.68 25.69 24.56 25.04
Tax Burden
0.78 0.76 0.78 0.78 0.77
Interest Burden
0.84 0.87 0.88 0.90 1.69
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.98 0.97 1.35 1.40 1.37
Currency in USD